MMP2 and breast carcinoma: Expression levels of ECM degrading proteases MMP2, MMP3, and MMP14 significantly increased in lung fibroblasts exposed to media conditioned by metastatic breast cancer cells as compared to controls (Fig. 1B, Supplementary Figure 1).